An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

The Thai authorities' mission is to increase inspections of products containing cannabis extracts. Read more at ...

Novato, California Monday, July 14, 2025, 16:00 Hrs [IST] ...

The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

DEMS ARE MAKING HAY: Today, Veasey is introducing legislation calling for the release of the Epstein files. In doing so, he’s aiming to not only force House Republicans into an uncomfortable vote ...

Takeda is on track to submit its much-hyped narcolepsy drug to regulators this fiscal year after the orexin receptor 2 (OX2R)-selective agonist ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is pleased to announce exciting new data from its Phase 1b clinical trial evaluating azer-cel (azercabtagene zapreleucel) in ...

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...